Structure Therapeutics creates life-changing medicines for patients using advanced computational and structure-based technology. Our platform combines the latest advancements in computational chemistry, visualization of molecular interactions, and data integration to design orally available, superior medicines that overcome current limitations in biologic and peptide drugs. We are advancing our clinical-stage pipeline of differentiated, efficacious and safe treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic and pulmonary conditions. At Structure, our team’s deep experience with complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development enables our bold vision: to design and develop world-class medicines with tremendous patient impact and broad commercial opportunity.
Location: United States, California, South San Francisco
Employees: 51-200
Total raised: $33M
Founded date: 2017
Investors 2
| Date | Name | Website |
| - | F-Prime Ca... | fprimecapi... |
| 23.01.2024 | Qiming Ven... | qimingvc.c... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 31.07.2022 | Series B | $33M | - |
Mentions in press and media 3
| Date | Title | Description | Source |
| 08.03.2024 | Structure Therapeutics to Present at Leerink Partners Global... | SAN FRANCISCO, March 08, 2024 (GLOBE NEWSWIRE) -- Structure Therapeutics Inc. (NASDAQ: GPCR), a clin... | einpresswi... |
| 29.09.2023 | Structure Therapeutics Announces $300 Million Private Placem... | - | tcgcrossov... |
| 18.07.2023 | The two-horse race to make blockbuster obesity drugs | The push to develop blockbuster weight loss drugs has turned into a two-horse race between Novo Nord... | axios.com/... |